N. Ciobanu
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immunodeficiency and Autoimmune Disorders
- T-cell and B-cell Immunology
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 10
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 3
-
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3
- Co-authors
- David H. Boldt (4 shared papers)Kim Margolin (4 shared papers)Geoffrey R. Weiss (2 shared papers)Richard I. Fisher (2 shared papers)Stephen P. Creekmore (1 shared paper)Janice P. Dutcher (1 shared paper)David Parkinson (1 shared paper)M Röper (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Immunotherapy (2 papers)Transfusion (1 paper)Journal of Hypertension (1 paper)American Journal of Clinical Nutrition (1 paper)
- Partner nations
- United StatesMoldovaItaly
In The Last Decade
N. Ciobanu
23 papers receiving 630 citations
Peers
Comparison fields: 5 of 79
- Immunology 372
- Oncology 285
- Hematology 98
- Pathology and Forensic Medicine 99
- Genetics 48
Countries citing papers authored by N. Ciobanu
This map shows the geographic impact of N. Ciobanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Ciobanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Ciobanu more than expected).
Fields of papers citing papers by N. Ciobanu
This network shows the impact of papers produced by N. Ciobanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Ciobanu. The network helps show where N. Ciobanu may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Ciobanu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 180 | |
| 2 | 1983 | 94 | |
| 3 | 1984 | 77 | |
| 4 | 1992 | 67 | |
| 5 | 1990 | 66 | |
| 6 | 1991 | 25 | |
| 7 | 1991 | 21 | |
| 8 | Etoposide as an in vitro purging agent for the treatment of acute leukemias and lymphomas in conjunction with autologous bone marrow transplantation. | 1986 | 21 |
| 9 | 1993 | 20 | |
| 10 | 2020 | 20 | |
| 11 | Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study. | 1994 | 16 |
| 12 | Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies. | 1993 | 14 |
| 13 | Malignant lymphomas, AIDS, and the pathogenic role of Epstein-Barr virus. | 1986 | 12 |
| 14 | 1983 | 10 | |
| 15 | 2022 | 9 | |
| 16 | Pilot study of high-dose mitoxantrone and busulfan plus autologous bone transplantation in patients with advanced malignancies. | 1995 | 8 |
| 17 | Reversible central nervous system toxicity associated with high-dose chlorambucil in autologous bone marrow transplantation for ovarian carcinoma. | 1987 | 4 |
| 18 | 2020 | 2 | |
| 19 | 1987 | 2 | |
| 20 | Phase i study of high dose continuous infusion interleukin 2 and autologous lymphokine activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinoma | 1989 | 1 |
About N. Ciobanu
N. Ciobanu is a scholar working on Oncology, Immunology, Genetics, Pathology and Forensic Medicine and Hematology, having authored 24 papers that have together received 672 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), CAR-T cell therapy research (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Immune Cell Function and Interaction (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Immunology (372 citations), Oncology (285 citations), Hematology (98 citations), Pathology and Forensic Medicine (99 citations) and Genetics (48 citations). N. Ciobanu has collaborated with scholars based in United States, Moldova and Italy. Frequent co-authors include David H. Boldt, Kim Margolin, Geoffrey R. Weiss, Richard I. Fisher, Stephen P. Creekmore, Janice P. Dutcher, David Parkinson, M Röper, Avi B. Markowitz and Karl Welte. Their work appears in journals such as Journal of Clinical Oncology, Journal of Immunotherapy, Transfusion, Journal of Hypertension and American Journal of Clinical Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.